Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 25.05.2026 1 Am J Clin Oncol 3 Am J Surg 2 Ann Oncol 10 Ann Surg Oncol 3 BMC Cancer 2 Br J Cancer 2 Breast Cancer 1 Breast Cancer (Dove Med Press) 5 Breast Cancer Res 2 Breast Cancer Res Treat 1 Breast J 1 Cancer 2 Cancer Chemother Pharmacol 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 3 Clin Breast Cancer 1 Eur J Cancer 1 Eur Radiol 1 Int J Cancer 1 J Clin Invest 1 J Clin Oncol 2 J Natl Cancer Inst 1 Mod Pathol 8 NPJ Breast Cancer 1 Oncogene 2 Oncol Rep 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiol Cardiothorac Imaging 1 Radiol Imaging Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. SHAHZAD M, Amin MK, Kasaeian A, Tariq SM, et al
   Outcomes With Immunotherapy in Hormone Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis.
   Am J Clin Oncol. 2026 May 15. doi: 10.1097/COC.0000000000001274.
   PubMed         Abstract available
   
   

   
   Am J Surg

2. BHAKTA P, Ayad S, Hossain MS, Black N, et al
   Mastectomy pain blocks: A comparison of preoperative versus intraoperative pectoralis nerve blocks: Mastectomy pectoralis nerve blocks comparison.
   Am J Surg. 2026;257:116936.
   PubMed         Abstract available
   
   
3. KADDOURA S, Malik S, Ganti L
   Predictors of stroke, myocardial infarction, and venous thromboembolism within 30 days of partial mastectomy.
   Am J Surg. 2026;257:116937.
   PubMed         Abstract available
   
   
4. SCHASCHINGER T, Niederegger T, Brandt J, Knoedler S, et al
   Identifying modifiable perioperative risk factors for wound healing complications after immediate autologous breast reconstruction.
   Am J Surg. 2026;257:117003.
   PubMed         Abstract available
   
   

   
   Ann Oncol

5. DUGO M, Huang CS, Egle D, Bermejo B, et al
   Longitudinal transcriptomic profiling identifies predictors of response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: results from the NeoTRIPaPDL1 trial.
   Ann Oncol. 2026 May 19:S0923-7534(26)00878-1. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   
6. SCHMID P, Wang HC, Lynce F, Asselah J, et al
   Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study.
   Ann Oncol. 2026 May 20:S0923-7534(26)00877-X. doi: 10.1016/j.annonc.2026.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

7. KALLES V, Mitrousias A, Vlachogiorgos A, Toesca A, et al
   ASO Author Reflections: Enhancing Technical Reproducibility and Ergonomics in Single-Port Endoscopic Nipple-Sparing Mastectomy.
   Ann Surg Oncol. 2026;33:5620-5621.
   PubMed         Abstract available
   
   
8. PETRELLI F, Pavesi V, Mercurio P, Burgoa L, et al
   Leaving the Axilla Untouched: Toward Surgical De-escalation in Early Luminal A Breast Cancer.
   Ann Surg Oncol. 2026 May 20. doi: 10.1245/s10434-026-19836.
   PubMed        
   
   
9. KALLES V, Mitrousias A, Vlachogiorgos A, Tsoti SM, et al
   Single-Port Endoscopic Nipple-Sparing Mastectomy Using a Handheld Motorized Articulating System: Technical Description and Initial Outcomes.
   Ann Surg Oncol. 2026;33:5606-5607.
   PubMed         Abstract available
   
   
10. SCARDINA L, D'Archi S, Accetta C, Carnassale B, et al
    Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission.
    Ann Surg Oncol. 2026;33:5598-5605.
    PubMed         Abstract available
    
    
11. MASHAL S, Melanson A, Apostolova C, Ferroum A, et al
    Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
    Ann Surg Oncol. 2026;33:5590-5597.
    PubMed         Abstract available
    
    
12. YOON J, Lee SB, Kim J, Chung IY, et al
    Omitting Axillary Surgery in Patients with Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery.
    Ann Surg Oncol. 2026;33:5574-5580.
    PubMed         Abstract available
    
    
13. HOLT L, Chamberlain V, Shern T, Gadd MA, et al
    Risk Stratification of Fibroepithelial Breast Lesions: Clinical and Ultrasound Features Associated with Fibroadenoma and Phyllodes Tumors.
    Ann Surg Oncol. 2026;33:5567-5573.
    PubMed         Abstract available
    
    
14. QU FL, Cheng JY, Jiang SH, Zhang Q, et al
    Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study.
    Ann Surg Oncol. 2026;33:5558-5566.
    PubMed         Abstract available
    
    
15. CHOI JE, Lee YW, Gwark S, Paek SH, et al
    Single-Port Robot-Assisted Nipple-Sparing Mastectomy: Main Analysis of a Retrospective Multicenter Study (SPROUT, KoREa-BSG 09).
    Ann Surg Oncol. 2026;33:5533-5540.
    PubMed         Abstract available
    
    
16. GIANMATTEO P, Andrea P, Erica AA, Antuono L, et al
    RADar Reflector LocalisatIOn-SCOUT((R)) for CarcinOma Mammae, a Prospective Observational Study Sharing Clinical Experience at the European Institute of Oncology in Milan: RADIOSO Milan Trial.
    Ann Surg Oncol. 2026;33:5513-5523.
    PubMed         Abstract available
    
    

    
    BMC Cancer

17. GOKCAY G, Efeturk N, Kucuk HI, Ugurlu ES, et al
    Comparison of breast cancer awareness and attitudes toward screenings in women with and without a family history.
    BMC Cancer. 2026 May 20. doi: 10.1186/s12885-026-16155.
    PubMed         Abstract available
    
    
18. GUO X, Li P, Hu S, Ding Y, et al
    Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.
    BMC Cancer. 2026 May 20. doi: 10.1186/s12885-026-16176.
    PubMed         Abstract available
    
    
19. KANO M, Furusawa A, Fukushima H, Takao S, et al
    Human epidermal growth factor receptor 3-targeted near-infrared photoimmunotherapy in a xenograft mouse model of breast cancer.
    BMC Cancer. 2026 May 18. doi: 10.1186/s12885-026-16170.
    PubMed         Abstract available
    
    

    
    Br J Cancer

20. KAVIANI A, Karkeabadi N, Farazmand B
    Primary tumour resection in de novo stage IV breast cancer: considerations from the PRIM-BC trial.
    Br J Cancer. 2026 May 20. doi: 10.1038/s41416-026-03469.
    PubMed        
    
    
21. KAHOUNOVA Z, Hruskova M, Drapela S, Naar O, et al
    Circulating tumour cell-derived xenograft as a preclinical platform for metastatic breast cancer.
    Br J Cancer. 2026 May 18. doi: 10.1038/s41416-026-03468.
    PubMed         Abstract available
    
    

    
    Breast Cancer

22. NISHIDA M, Tou R, Kato H, Hirotani N, et al
    Comparative evaluation of treatment recommendations generated by generative AI and breast cancer specialists for advanced and recurrent breast cancer: a multidimensional assessment of evidence interpretation and clinical decision support.
    Breast Cancer. 2026 May 20. doi: 10.1007/s12282-026-01858.
    PubMed         Abstract available
    
    
23. NAKATSU K, Ono Y, Yoshimura M, Hirata K, et al
    Clinical outcomes of postoperative radiotherapy with regional nodal irradiation excluding internal mammary lymph nodes in breast cancer: a multi-institutional retrospective analysis.
    Breast Cancer. 2026 May 18. doi: 10.1007/s12282-026-01864.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

24. TIAN C, Qiu J, Fan Y, Yu H, et al
    The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer.
    Breast Cancer (Dove Med Press). 2026;18:595222.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

25. YE S, Jin Z, Li W, Wei G, et al
    Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives.
    Breast Cancer Res. 2026 May 18. doi: 10.1186/s13058-026-02303.
    PubMed         Abstract available
    
    
26. SANVIDO VM, Bromberg SE, Waitzberg AFL, Gomes JO, et al
    Cryoablation for early-stage invasive breast cancer: pathologic and imaging outcomes from the prospective FIRST trial.
    Breast Cancer Res. 2026 May 19. doi: 10.1186/s13058-026-02302.
    PubMed         Abstract available
    
    
27. DE NEGREIROS BOTAN R, de Sousa JB
    Corepam: a 24-gene PAM50-derived expression score with cross-platform external validation for breast cancer prognosis.
    Breast Cancer Res. 2026 May 21. doi: 10.1186/s13058-026-02298.
    PubMed         Abstract available
    
    
28. YU W, Jiang L
    CAF-derived exosomes drive trastuzumab resistance in HER2-positive breast cancer via YAP-USP8-HER2 axis activation.
    Breast Cancer Res. 2026 May 15. doi: 10.1186/s13058-026-02288.
    PubMed         Abstract available
    
    
29. HUANG X, Li T, Ye S, Lan Y, et al
    Tamoxifen-pretreated MSC exosomes promote endocrine resistance in ER-positive breast cancer cells through the miR-137/Serpina3 axis: a mechanistic study.
    Breast Cancer Res. 2026 May 21. doi: 10.1186/s13058-026-02306.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

30. STICKLAND A, Tao X, Kidwell K, Henry NL, et al
    Change in practice patterns over time for endocrine therapy and radiation therapy in women with breast cancer age 65 and older.
    Breast Cancer Res Treat. 2026;217:37.
    PubMed         Abstract available
    
    
31. GABA AG, Cao L, Renfrew RJ
    The applicability of the 21-gene assay to inform chemotherapy benefit in lymph node positive hormone receptor positive male breast cancer.
    Breast Cancer Res Treat. 2026;217:36.
    PubMed         Abstract available
    
    

    
    Breast J

32. HUANG C, Parmar P, Habboosh N, Bhimani F, et al
    Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS.
    Breast J. 2026;2026:e5479226.
    PubMed         Abstract available
    
    

    
    Cancer

33. ROJAS KE
    Understudied and overlooked: Addressing sexual quality of life for couples facing metastatic breast cancer.
    Cancer. 2026;132:e70450.
    PubMed        
    
    

    
    Cancer Chemother Pharmacol

34. BUITELAAR PLM, Pluim D, Hanssens S, Kerbage Y, et al
    Transfer of trastuzumab and pertuzumab into human breast milk: a case report.
    Cancer Chemother Pharmacol. 2026;96:53.
    PubMed         Abstract available
    
    
35. LAUNAY M, Puszkiel A, Genevee T, Bellesoeur A, et al
    The hidden impact of renal impairment on ribociclib exposure and co-medications: a case report.
    Cancer Chemother Pharmacol. 2026;96:54.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

36. ABUBAKAR M, Koka H, Lee PMY, Tang HYN, et al
    Integrating In Situ Immune Expression Landscape with Gene Expression-Based Subtyping to Characterize Breast Cancer Heterogeneity.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available
    
    

    
    Cancer Lett

37. SABIT H, Ghazy A, Albogami KFKM, Abdelhadi OE, et al
    Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions.
    Cancer Lett. 2026;653:218588.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

38. CARLOS MIR, Mello JS, Marcalo de Tolosa AL, Cardoso MR, et al
    Immune Checkpoint Inhibitors in Elderly Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Subgroup Evidence.
    Clin Breast Cancer. 2026 Apr 14:S1526-8209(26)00057.
    PubMed         Abstract available
    
    
39. ANTONINI M, Mattar A, Madeira M, Cavalcante FP, et al
    Severe Adverse Events in Neoadjuvant Therapy of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Phase 3 Trials.
    Clin Breast Cancer. 2026 Apr 28:S1526-8209(26)00069.
    PubMed         Abstract available
    
    
40. LIFRIERI A, Malhotra S, Yu AT, Chan L, et al
    Expectation Versus Reality: Impact of the Choosing Wisely Campaign on Routine Use of Sentinel Lymph Node Biopsy in Women Over 70 With Early-Stage Breast Cancer in an Academic Institution.
    Clin Breast Cancer. 2026;26:71-76.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

41. CONFORTI F, Sala I, Pala L, Bendoni M, et al
    "Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?".
    Eur J Cancer. 2026;241:116796.
    PubMed         Abstract available
    
    

    
    Eur Radiol

42. BELLINI C, Bicchierai G, Maiello C, Amato F, et al
    Early, delayed, or combined contrast-enhanced mammography for detecting residual disease after neoadjuvant chemotherapy in breast cancer.
    Eur Radiol. 2026 May 15. doi: 10.1007/s00330-026-12633.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. CHEN Q, Campbell I, Elwood M, Cavadino A, et al
    Breast Cancer Outcomes From Ductal Carcinoma In Situ: A Population-Based Cohort Study.
    Int J Cancer. 2026 May 20. doi: 10.1002/ijc.70559.
    PubMed         Abstract available
    
    

    
    J Clin Invest

44. LIN Q, Luo J, Duan Z, Luo J, et al
    Targeting RANKL-independent osteoclastogenesis overcomes denosumab resistance in models of ER+ breast cancer bone metastasis.
    J Clin Invest. 2026;136:e199285.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

45. GLUZ O, Nitz UA, Christgen M, Kuemmel S, et al
    Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer.
    J Clin Oncol. 2026 May 18:JCO2501047. doi: 10.1200/JCO-25-01047.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

46. NADER-MARTA G, Zheng Y, Rosenberg SM, Dibble KE, et al
    Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer.
    J Natl Cancer Inst. 2026 May 18:djag152. doi: 10.1093.
    PubMed         Abstract available
    
    
47. YU S, Wang X, Ge H
    RE: Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
    J Natl Cancer Inst. 2026 May 19:djag149. doi: 10.1093.
    PubMed        
    
    

    
    Mod Pathol

48. XU J, Gao Y, Liu Y, Zhang H, et al
    Comprehensive Clinicopathologic Evaluations of 149 Metaplastic Carcinomas of the Breast Treated With Neoadjuvant and Adjuvant Chemotherapy.
    Mod Pathol. 2026;39:100989.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

49. GAO Q, Goh SNS, Khng AJ, Hartman M, et al
    Women's preferences for breast cancer risk-reducing medications: a discrete choice experiment study.
    NPJ Breast Cancer. 2026 May 21. doi: 10.1038/s41523-026-00972.
    PubMed         Abstract available
    
    
50. CANDO LF, Sandhu J, Ju Z, Albarracin CT, et al
    Targeting microRNA let-7b-5p-mediated aberrant androgen receptor signaling for prevention of hormone receptor-negative breast cancer.
    NPJ Breast Cancer. 2026 May 20. doi: 10.1038/s41523-026-00938.
    PubMed         Abstract available
    
    
51. FANUCCI K, Rozenblit M, Quintanilha JCF, Graf RP, et al
    Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results.
    NPJ Breast Cancer. 2026 May 20. doi: 10.1038/s41523-026-00965.
    PubMed         Abstract available
    
    
52. ALOSS K, Frederick MI, Hassan S
    Sequencing PARP inhibitors in breast cancer: lessons learned and emerging insights.
    NPJ Breast Cancer. 2026 May 15. doi: 10.1038/s41523-026-00963.
    PubMed         Abstract available
    
    
53. RAKICI SY, Cetin B, Aydin E, Gursel B, et al
    Facing death: the last drawings of a woman with breast cancer at the end of life.
    NPJ Breast Cancer. 2026;12:72.
    PubMed         Abstract available
    
    
54. WANG CC, Krishnan S, Wang YH, Hsu KC, et al
    Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer.
    NPJ Breast Cancer. 2026 May 15. doi: 10.1038/s41523-026-00954.
    PubMed         Abstract available
    
    
55. MARCHIO C, Rojo F, Copson ER, Schmitt F, et al
    Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer.
    NPJ Breast Cancer. 2026 May 15. doi: 10.1038/s41523-026-00968.
    PubMed         Abstract available
    
    
56. VELASCO-SUELTO J, Quiros-Ortega ME, Pascual J, Godoy-Ortiz A, et al
    Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.
    NPJ Breast Cancer. 2026 May 20. doi: 10.1038/s41523-026-00970.
    PubMed         Abstract available
    
    

    
    Oncogene

57. CHEN B, Ma K, Zhong W, Wang Y, et al
    circPARPBP promotes cancer stemness and chemoresistance in triple-negative breast cancer through recruiting SRCAP complex to activate CCL20 transcription.
    Oncogene. 2026 May 21. doi: 10.1038/s41388-026-03819.
    PubMed         Abstract available
    
    

    
    Oncol Rep

58. FENG H, He L, Umar T, Wang H, et al
    Combination of ivermectin and metformin promotes autophagy in MCF?7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway.
    Oncol Rep. 2026;56:131.
    PubMed         Abstract available
    
    
59. ZHU L, Li XX, Shi L, Wu J, et al
    [Corrigendum] Rapamycin enhances the sensitivity of ER?positive breast cancer cells to tamoxifen by upregulating p73 expression.
    Oncol Rep. 2026;56:134.
    PubMed         Abstract available
    
    

    
    PLoS One

60. STAYOUSSEF M, Habel A, Xu W, Bessaad M, et al
    Multiplex profiling of 16 immune checkpoints identifies novel serum biomarker panels for breast cancer detection and TNBC stratification: A case-control study.
    PLoS One. 2026;21:e0348953.
    PubMed         Abstract available
    
    
61. MUKHERJEE A, Goyal P, Tripathi R, Goyal S, et al
    Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India.
    PLoS One. 2026;21:e0349196.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. KAYA M, Johnsson O, Issdisai N, Paul S, et al
    NRF2 activation by myeloid cell-derived oxidative stress induces SNAI-driven features of EMT in breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2521491123.
    PubMed         Abstract available
    
    

    
    Radiol Cardiothorac Imaging

63. MOUSSEAUX E, Craiem D, Vliegenthart R, Jacob S, et al
    Cardiac Radiation Dose and Subclinical Coronary Artery Disease Progression after Breast Cancer Radiotherapy: 2-year Cardiac CT Results from the EARLY-HEART Study.
    Radiol Cardiothorac Imaging. 2026;8:e250342.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

64. WOODARD S, Oluyemi E, Hidayati A, Anugrha HW, et al
    A Global Partnership to Address Breast Cancer Challenges in Indonesia through a Breast Radiology Training Program.
    Radiol Imaging Cancer. 2026;8:e260103.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum